5 completed, 1 unknown. 6 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 6 | Completed 5, Unknown 1 |
Follow hecolin: new trials by email Literature Review of hecolin trials Research Report on hecolin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Immunogenicity and Safety of Co-immunization With Cecolin and Hecolin Cecolin, Hecolin - Human Papilloma Virus Infection Type 16, Human Papilloma Virus Infection Type 18 | Phase 4 | Unknown | Xiamen Innovax Biotech Co., Ltd | 480 | 2021-10-25 | 2022-06-13 |
| Effectiveness Trial to Evaluate Protection of Pregnant Women by Hepatitis E Vaccine in Bangladesh. Hecolin, Hepa-B - Hepatitis E Infection | Phase 4 | Completed | Norwegian Institute of Public Health | 19460 | 2017-10-02 | 2024-08-15 |
| A Study on the Recombinant Hepatitis E Vaccine (Escherichia Coli) (Accelerated Vaccination Schedule) Recombinant Hepatitis E Vaccine (Escherichia Coli) - Hepatitis E | Phase 4 | Completed | Xiamen Innovax Biotech Co., Ltd | 125 | 2017-05-25 | 2019-02-21 |
| A Phase Ⅳ Clinical Trial of the Recombinant Hepatitis E Vaccine (Escherichia Coli)(the Chronic Hepatitis B Patients ) Recombinant Hepatitis E Vaccine (Escherichia Coli) - Hepatitis E | Phase 4 | Completed | Xiamen Innovax Biotech Co., Ltd | 475 | 2016-08-01 | 2019-07-25 |
| A Phase Ⅳ Clinical Trial of the Recombinant Hepatitis E Vaccine (Escherichia Coli) Recombinant Hepatitis E Vaccine (Escherichia Coli) - Hepatitis E | Phase 4 | Completed | Xiamen Innovax Biotech Co., Ltd | 600 | 2015-04-01 | 2016-05-18 |
| Phase Ⅳ Clinical Trial of Recombinant Hepatitis E Vaccine（Hecolin®） Recombinant (E. Coli) Hepatitis E Vaccine - Hepatitis E | Phase 4 | Completed | Jun Zhang | 601 | 2014-06-01 | 2018-08-17 |
Hepatitis E (5)
Xiamen Innovax Biotech Co., Ltd (4) · Jun Zhang (1) · Norwegian Institute of Public Health (1)
China (5) · Bangladesh (1)
Zhiping Chen (2) · Aiqiang Xu (1) · K Zaman, PhD (1) · Susanne Dudman, MD, PhD (1) · Zhenggang Jiang (1)
PMID 30711651, PMID 31262585, PMID 31959609, PMID 36599736, PMID 39030060, PMID 39030061, PMID 40733519, PMID 41276263